Carlos Domínguez-Vargas

Carlos Domínguez-Vargas

Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico
orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2026 in Medical Sciences Forum
Verified
Conference Paper
Open access
PDF file
BPBarbarita Sánchez Peña
Barbarita Sánchez Peña
Carlos Domínguez-VargasCarlos Domínguez-Vargas
Carlos Domínguez-Vargas
PPPaloma Marylí Prado-López
Paloma Marylí Prado-López
DTDaniela Alejandra Torres-Rodríguez
Daniela Alejandra Torres-Rodríguez
Bruxism is increasingly recognized as a psychosomatic behavior influenced by stress, anxiety, and sleep disturbances, which generates occlusal forces of non-physiological magnitude, potentially compromising the stability of dental implants. This narrative review examines the causal pathway linking psychological factors, bruxism, and implant complications. The literature from PubMed, Scopus, and Cochrane (2000–2025) was analyzed. Evidence consistently associates psychosocial stressors with increased mechanical complications, while biological outcomes remain heterogeneous. Digital occlusal analysis, finite element modeling, and AI-based monitoring show promise for early overload detection. An interdisciplinary model integrating dentistry, psychology, and sleep medicine is proposed to optimize implant outcomes and guide future research.

5 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Carlos Domínguez-VargasCarlos Domínguez-Vargas
Carlos Domínguez-Vargas
Jesús Eduardo García HernándezJesús Eduardo García Hernández
Jesús Eduardo García Hernández
Emiliano Peña-DuránEmiliano Peña-Durán
Emiliano Peña-Durán
SRSamantha Jonnue Ramírez-Flores
Samantha Jonnue Ramírez-Flores
UGUlises Moisés González-Reyes
Ulises Moisés González-Reyes
PPPaloma Marylí Prado-López
Paloma Marylí Prado-López
Early-life exposure to toxic metals remains a major global public health concern, particularly for children, whose developing neuroendocrine and metabolic systems are highly vulnerable. Within the exposome and Developmental Origins of Health and Disease (DOHaD) frameworks, this narrative review synthesizes human evidence on pediatric exposure to lead (Pb), mercury (Hg), cadmium (Cd), and arsenic (As) and its associations with neurodevelopmental, metabolic, and endocrine outcomes. We primarily examined epidemiological studies, systematic reviews, and meta-analyses published between 2010 and 2025 that relied on biomonitoring-based exposure assessment and appropriate adjustment for socioeconomic status and passive smoking, while seminal earlier studies were considered to contextualize biological mechanisms and conceptual frameworks. The evidence for neurodevelopmental toxicity is the most consistent, with prenatal and early childhood exposure to Pb and Hg robustly associated with adverse cognitive, behavioral, and motor outcomes and no identified safe exposure threshold for lead. In contrast, associations with obesity and pubertal timing are more heterogeneous and metal-specific, reflecting nonlinear dose–response relationships, sex-specific susceptibility, and critical exposure windows. Emerging data indicate that metals may act as metabolism- and endocrine-disrupting chemicals, with effects amplified by mixture exposures and adverse social conditions, and partially modified by nutritional status. Overall, the findings support life-course–oriented, biomonitoring-based research and prevention strategies that address cumulative exposures and developmental vulnerability to reduce long-term disease risk.

9 June 2026 in Medical Sciences Forum
Verified
Conference Paper
Open access
PDF file
Carlos Domínguez-VargasCarlos Domínguez-Vargas
Carlos Domínguez-Vargas
Jesús Eduardo García HernándezJesús Eduardo García Hernández
Jesús Eduardo García Hernández
Emiliano Peña-DuránEmiliano Peña-Durán
Emiliano Peña-Durán
MPMiranda Citlali Pérez-Castellón
Miranda Citlali Pérez-Castellón
DMDante Joel Márquez-González
Dante Joel Márquez-González
GAGerardo Amaya-Tapia
Gerardo Amaya-Tapia
Postherpetic neuralgia (PHN) is a chronic neuropathic pain condition that arises following varicella-zoster virus reactivation and represents a significant clinical burden. Despite known risk factors, the genetic basis of PHN remains poorly understood. This study aimed to identify genetic variants associated with PHN through the secondary analysis of GWAS summary data (GCST012124). One genome-wide significant locus (KIF1B) and several suggestive variants (PTPRZ1, PRKCE, CXCR4) were identified. These genes converge on pathways related to axonal transport, neuroinflammation, and nociceptive sensitization. Findings support a multifactorial genetic contribution to PHN and highlight potential targets for future research and therapeutic development.

28 May 2026 in Medical Sciences Forum
Verified
Conference Paper
Open access
PDF file
Carlos Domínguez-VargasCarlos Domínguez-Vargas
Carlos Domínguez-Vargas
Jesús Eduardo García HernándezJesús Eduardo García Hernández
Jesús Eduardo García Hernández
Emiliano Peña-DuránEmiliano Peña-Durán
Emiliano Peña-Durán
PPPaloma Marylí Prado-López
Paloma Marylí Prado-López
BPBarbarita Sánchez Peña
Barbarita Sánchez Peña
SNSamuel Neri-Mendoza
Samuel Neri-Mendoza
Multiple sclerosis (MS) is associated with neuroinflammation, autonomic dysfunction, and dysregulation of the hypothalamic–pituitary–adrenal axis. This cross-sectional study evaluated the relationship between salivary cortisol, xerostomia, nitric oxide (NO), and anxiety in 39 patients with MS. Cortisol levels were higher in patients with xerostomia and showed a weak-to-moderate positive correlation with xerostomia (ρ = 0.32; p = 0.047) and a moderate negative correlation with NO (ρ = −0.46; p = 0.0035). No association was found with anxiety or disease duration. These findings suggest a potential neuroendocrine–salivary pathway linking stress biomarkers with glandular dysfunction in MS.

19 August 2026 in Medical Sciences Forum
Verified
Conference Paper
Open access
PDF file
Carlos Domínguez-VargasCarlos Domínguez-Vargas
Carlos Domínguez-Vargas
Jesús Eduardo García HernándezJesús Eduardo García Hernández
Jesús Eduardo García Hernández
Emiliano Peña-DuránEmiliano Peña-Durán
Emiliano Peña-Durán
PPPaloma Marylí Prado-López
Paloma Marylí Prado-López
SRSamantha Jonnue Ramírez-Flores
Samantha Jonnue Ramírez-Flores
UGUlises Moisés González-Reyes
Ulises Moisés González-Reyes
Clinically isolated syndrome (CIS) represents the first demyelinating event suggestive of multiple sclerosis (MS), with variable risk of progression. This study aimed to identify clinical and paraclinical predictors of conversion to clinically definite MS in a cohort of 273 patients. Multivariate analysis demonstrated that periventricular and infratentorial MRI lesions, as well as oligoclonal bands, were the strongest independent predictors of conversion. Additional factors included abnormal somatosensory evoked potentials and polysymptomatic presentation. These findings highlight the importance of integrating radiological, immunological, and clinical markers to improve early risk stratification and guide therapeutic decision-making in patients with CIS.

11 February 2026 in Medical Sciences Forum
Verified
Conference Paper
Open access
PDF file
Carlos Domínguez-VargasCarlos Domínguez-Vargas
Carlos Domínguez-Vargas
BPBarbarita Sánchez Peña
Barbarita Sánchez Peña
Emiliano Peña-DuránEmiliano Peña-Durán
Emiliano Peña-Durán
SRSamantha Jonnue Ramírez-Flores
Samantha Jonnue Ramírez-Flores
Sjögren’s syndrome (SS) is a chronic autoimmune disease characterized by severe hyposalivation and mucosal fragility, conditions that significantly complicate prosthetic rehabilitation. Reduced salivary flow compromises denture retention, increases mucosal trauma, and predisposes patients to infections such as oral candidiasis, limiting the success of conventional tissue-supported prostheses. This work summarizes current evidence on prosthetic management strategies in SS, highlighting the role of optimized biomaterials, digital manufacturing technologies, and implant-supported solutions. Emphasis is placed on multidisciplinary care, adjunctive pharmacological management of xerostomia, and long-term maintenance protocols to improve function, comfort, and quality of life in this complex patient population.